Acinar tissue - The flowers of diabetes Credit: Odra Noel
Cambridge has been awarded two of Wellcome's eight new Discovery Research Platforms, the global charitable foundation announced today. Acinar tissue - The flowers of diabetes Credit: Odra Noel The Discovery Research Platforms (DRPs) will be home to transformative research environments that empower researchers to overcome specific barriers holding back progress in their fields of research. They aim to accelerate research for the benefit of the wider global research community, with researchers and teams developing new tools, knowledge and capabilities to help unlock new findings about life, health and wellbeing. Michael Dunn, Director of Discovery Research at Wellcome, said: -Discovery research is essential to advancing our ability to understand and improve health. But in addition to researchers- bold and imaginative ideas, we know that new tools, methods and capabilities are also needed to unlock new avenues of research that can disrupt and transform the research landscape globally. The two Cambridge DRPs, which will receive £9million each over seven years, are: The Discovery Research Platform for Tissue Scale Biology - which seeks to move stem cell biology to the tissue and organ scale of research, creating a new network of local and international researchers to enable strategies that capitalise on new in vitro models to develop better treatments for human patients. Professor Bertie Gottgens, Director of the Wellcome-MRC Cambridge Stem Cell Institute, said: "I am delighted that Wellcome will support our ambition to build a new Discovery Research Platform to provide international leadership for Tissue Scale Biology.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
